Blueprint MedTech Awardees
NIH’s Blueprint MedTech program has issued eight Optimizer project awards from its first competition cycle. The first round of these awards totals $11M. These projects will be administered by the two Blueprint MedTech Incubator Hubs—CIMIT’s Center for Innovative NeuroTech Advancement (CINTA) and NeuroTech Harbor (NTH).
In addition to the Innovator awards, Blueprint MedTech is extending Seedling awards to 17 innovators whose applications represented special merit but were not quite ready for a larger development award. Seedling awards provide support for six months, a $25,000 stipend, and $25,000 to hire subject matter experts. For these, mentors will work with awardees to help resolve specifically identified gap(s) on the path to commercialization. Each of these awardees also has access to $50,000 of in-kind support via mentoring, regulatory consulting, and other commercialization training.
Finally, Blueprint MedTech also has Translator project awards made via UG3/UH3 and U44 cooperative agreement funding mechanisms after NIH grant review. We have listed the first four awards made via these funding mechanisms below as well.
Blueprint MedTech Cycle 1 Optimizer awardees:
For additional details on the Optimizer awards, please see this NIBIB Science Highlight.
|
Awardee Institution |
Optimizer Project Title |
Funding NIH Institute(s) |
|---|---|---|
|
Icahn School of Medicine at Mount Sinai, New York; University of California, San Diego; and Johns Hopkins University, Baltimore |
MonOs |
NIDA |
|
NeuraStasis, Inc., Houston* |
Development/Testing of BlueStem Dual Nerve Stimulation Device for Ischemic Stroke |
NINDS |
|
Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton* |
External focused ultrasound modulation of the dorsal root ganglia |
NIDA and NINDS |
|
Endovascular Horizons and University of California San Francisco |
Embodrain technology for chronic subdural hematomas |
NINDS |
|
Boston University and Harvard University, Boston* |
reNeu propulsion rehabilitation platform for gait restoration after neurological disease |
NICHD/National Center for Medical Rehabilitation Research (NCMRR), and NINDS |
|
Northern Arizona University and Biomotum, Inc., Flagstaff |
A wearable rehabilitation robot for children to use at home |
NINDS |
|
Openwater, Inc., San Francisco |
Wearable noninvasive, transcranial focused ultrasound neuromodulation with near-infrared optical neuromonitoring |
BRAIN Initiative |
|
SecondWave Systems, Inc., Minneapolis |
Treatment of Facial Pain using an Injectable Ultrasonically Powered Neurostimulator |
NIDCR |
*participant in the 2022 Blueprint MedTech pilot
Blueprint MedTech Cycle 1 Seedling awardees (see descriptions from the Neurotech Harbor web page):
|
Awardee Institution |
Seedling Project Title |
Funding NIH Institute(s) |
|---|---|---|
|
UCSF, San Francisco |
An Implantable Closed-Loop Neuromodulation Device for Neuropsychiatric Disorders |
BRAIN Initiative |
|
Lundquist Institute, Los Angeles |
Endovascular Electrode Device for Transvenous Electroencephalography |
BRAIN Initiative |
|
Johns Hopkins University, Maryland |
Photoacoustic Retinal Prosthesis |
NEI |
|
Asayena, Inc., La Jolla |
Neuromodulation Device for Restoration of Motor Function |
NICHD/NCMRR |
|
MIT, Cambridge |
Magnetomicrometry |
NICHD/NCMRR, NINDS |
|
Motif Neurotech, Inc., Houston |
Minimally Invasive Implants for Treatment-Resistant Depression |
BRAIN Initiative |
|
UNandUP, LLC, St.Louis |
Magneto-Thrombolysis to Improve Acute Ischemic Stroke Care |
NINDS |
|
JUAD Neurotech, Irvine |
Minimally Invasive Device for Epilepsy Surgery |
NINDS, BRAIN Initiative |
|
Longeviti Neuro Solutions, Baltimore |
Monitoring GBM Through Implantable Ultrasound Transducer |
NINDS |
|
Johns Hopkins University, Baltimore |
A Non-Invasive Imaging Device to Modernize Treatment of Peripheral Nerve Injuries |
NINDS |
|
FemiStim, Gainesville Florida |
FemiStim, the Sexual Health Neurostimulator for Victims of Female Genital Mutilation |
NINDS |
|
Arizona State University, Phoenix |
Wireless, Injectable Neurostimulators (WINS) for Treating Chronic Migraine (CM) |
NINDS |
|
University of Utah, Salt Lake City |
Drug Delivering Nervewrap for Peripheral Nerve Regeneration |
NINDS |
|
Neuroview Technology, Inc., Englewood, New Jersey |
Subgaleal Hyper-chronic EEG Monitoring Platform |
NINDS |
|
Johns Hopkins University, Baltimore |
Development of a Smart Cerebrospinal Fluid Management Implant in Patients with Spinal Cord Injury |
NINDS |
|
Johns Hopkins University, Baltimore |
Implantable Ultrasound Transducer for Remote Spinal Cord Injury Monitoring |
NINDS |
|
MacHouse Designs, LLC, Loveland, Colorado |
In vivo Visualization of Peripheral Nerves Using Novel CT Contrast Agents |
NIDCR |
BPMT Translator Awards:
The Blueprint MedTech program also has Translator Cooperative Agreement awards, Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional), PAR-21-315 and Blueprint MedTech: Small Business Translator (U44 - Clinical Trial Optional), PAR-21-282. The following awards have been made in these programs to date:
- U44 DA059380-01 John Konsin, PI, Prapela, Inc.
- Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity
- U44 NS136026-01A1 (BRAIN NOSI) Hung-Yu Lin, PI, Neuro42, Inc.
- Portable Intraoperative MRI for Neurosurgery
- UG3 NS130338-01A1 Richard Webb, PI, Rhaeos, Inc.
- Development of wireless, wearable flow sensors for continuous, long-term tracking of cerebrospinal fluid dynamics in patients with hydrocephalus
- UG3 NS135551-01 (HEAL NOSI) Charles Caskey, PI, Vanderbilt University Medical Center
- Translating an MR-guided focused ultrasound system for first-in-human precision neuromodulation of pain circuits